发明名称 |
Cytotoxicity mediation of cells evidencing surface expression of CD44 |
摘要 |
<p>Disclosed is the use of an isolated monoclonal antibody, or antigen binding fragment thereof, produced by the hybridoma cell line deposited with ATCC as accession number PTA-4621 for the manufacture of a medicament for the treatment of a breast tumor that is negative for Her2 expression.</p> |
申请公布号 |
NZ550045(A) |
申请公布日期 |
2009.10.30 |
申请号 |
NZ20050550045 |
申请日期 |
2005.03.23 |
申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
YOUNG, DAVID S F;HAHN, SUSAN E;FINDLAY, HELEN P |
分类号 |
A61K39/395;A61K47/48;A61K49/00;A61P35/00;C07K16/00;C07K16/28;C07K16/30;G01N33/50;G01N33/566;G01N33/567;G01N33/569;G01N33/574 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|